Type 1 diabetes is caused by the immune system attacking and destroying the insulin-producing cells in the pancreas. Unlike type 2 diabetes, which involves the body becoming resistant to insulin, type 1 is an autoimmune disease where the body’s own defense system turns on itself. The destruction can begin months or even years before any symptoms appear, and by the time someone is diagnosed, a significant portion of their insulin-producing cells are already gone.
How the Immune System Destroys Insulin-Producing Cells
The pancreas contains clusters of cells called islets, and within those islets are beta cells, which are the only cells in the body that produce insulin. In type 1 diabetes, a specific type of immune cell (the same kind that normally kills virus-infected cells) identifies beta cells as foreign threats and begins destroying them. These immune cells recognize proteins on the surface of beta cells, latch onto them, and kill them using the same chemical weapons they’d deploy against an infection.
The damage extends beyond the cells that are directly attacked. Research published in the journal Diabetes found that when immune cells kill beta cells, the dying cells release inflammatory signals that affect their neighbors. Nearby beta cells that weren’t directly targeted start producing less insulin and show signs of stress and dysfunction. This cascading damage helps explain why the disease can progress rapidly once it reaches a tipping point: the immune attack itself creates an environment that weakens surrounding cells.
The Role of Genetics
Type 1 diabetes has a strong genetic component, though it’s not as simple as inheriting a single gene. The most important genetic risk factor involves a set of genes that control how the immune system distinguishes “self” from “foreign.” Certain variants of these genes dramatically increase risk. One high-risk combination carries an odds ratio of 8.39, meaning a person with that variant is roughly eight times more likely to develop type 1 diabetes than someone without it. A closely related variant, differing by just one gene in the combination, drops to an odds ratio of 0.35, actually making it protective. The difference between high risk and low risk can come down to remarkably small genetic distinctions.
People who carry two specific high-risk variants (one from each parent) face the greatest odds. But genetics alone don’t seal anyone’s fate. Most people with high-risk genes never develop type 1 diabetes, and some people who develop it don’t carry the highest-risk variants. This is why researchers believe environmental factors act as triggers in genetically susceptible individuals.
Environmental Triggers
Something in the environment appears to set off the autoimmune process in people whose genes make them vulnerable. Several triggers have been studied, though no single one has been confirmed as “the” cause.
Viral Infections
Certain viruses, particularly a group called Coxsackie B viruses, have been linked to the onset of type 1 diabetes. Researchers have found that specific strains of Coxsackie B4 can induce diabetes in mice, and systematic reviews of human studies have found a consistent association between enterovirus infections and type 1 diabetes. The leading theory is that these viruses either directly damage beta cells or, more likely, trigger an immune response that cross-reacts with beta cell proteins because the viral proteins look similar enough to confuse the immune system.
Vitamin D and Geography
Type 1 diabetes is more common in countries farther from the equator. Finland and Sardinia have some of the highest rates in the world. A recent meta-analysis confirmed a positive association between the latitude of a person’s residence and their risk. One explanation is vitamin D, which plays a role in regulating immune function. Children newly diagnosed with type 1 diabetes consistently have lower vitamin D levels than healthy children of the same age. Whether low vitamin D is a contributing cause or a consequence of the disease process is still being worked out, but the geographic pattern is striking and consistent across populations.
Gut Bacteria in Early Childhood
The trillions of bacteria living in the gut help train the immune system during infancy and early childhood. Children who go on to develop type 1 diabetes show a measurable decline in gut bacterial diversity before diagnosis. One cohort study tracked children over time and found that the ratio of two major bacterial groups shifted as children developed the early immune markers of diabetes. Importantly, this decline in diversity was specific to children who eventually progressed to full disease, not those whose immune markers appeared but never advanced.
Breastfeeding appears to be protective. Breast-fed infants develop a more stable gut microbiome dominated by beneficial bacteria compared to formula-fed infants, and breast milk has been identified as an independent factor associated with lower type 1 diabetes incidence. One study also found that giving probiotics in the first four weeks of life reduced the risk of early immune markers in genetically susceptible infants.
How the Disease Develops in Stages
Type 1 diabetes doesn’t appear overnight. Researchers now recognize three distinct stages, and understanding them changes how you think about the “cause” versus the diagnosis.
In Stage 1, the immune system has already begun its attack. Blood tests can detect autoantibodies (proteins that target beta cells), but blood sugar levels are still completely normal and there are no symptoms whatsoever. A person in Stage 1 could go months or years without knowing anything is happening. This stage is now considered the true start of the disease.
In Stage 2, enough beta cells have been lost that blood sugar regulation starts to slip. Lab tests show abnormal blood sugar levels, but the person still feels fine and has no obvious symptoms. The immune attack is progressing, and the body’s ability to compensate is eroding.
Stage 3 is the clinical diagnosis most people think of as “getting diabetes.” By this point, beta cell loss is significant enough to cause noticeable symptoms: excessive thirst, frequent urination, unexplained weight loss, and fatigue. This is typically when someone ends up in a doctor’s office or emergency room.
The gap between Stage 1 and Stage 3 varies widely. In young children, it can be as short as a few months. In adults, it can stretch over several years. Screening programs that test for autoantibodies in at-risk individuals (such as relatives of people with type 1 diabetes) can now identify the disease at Stage 1, long before any symptoms emerge.
How Autoantibodies Confirm the Cause
The autoantibodies that appear in the blood are both evidence of the autoimmune cause and a diagnostic tool. Three are most commonly measured: one targets an enzyme in beta cells (GAD65), another targets a protein involved in insulin secretion (IA-2), and a third targets a zinc transporter on beta cells (ZnT8). In a large study of youth with diabetes, 66% tested positive for at least one of these autoantibodies, with 31% positive for two and 13% positive for all three. Each autoantibody is independently associated with insulin deficiency, confirming that the more targets the immune system is attacking, the more thoroughly beta cell function is compromised.
Testing positive for two or more autoantibodies is the key threshold. At that point, the lifetime risk of progressing to clinical type 1 diabetes is extremely high, which is why two or more positive results define Stage 1 of the disease even when blood sugar is perfectly normal.
Why Type 1 Diabetes Is Increasing
Type 1 diabetes incidence has been rising in Western countries for decades, particularly among young children. The disease is more common in firstborn children and in higher-income families. This pattern initially led some researchers to propose a “hygiene hypothesis,” suggesting that children in cleaner environments don’t get enough early infections to properly calibrate their immune systems. However, the evidence for this in type 1 diabetes is more complicated than in allergies or asthma, and many researchers consider the link premature. The rising rates likely reflect a combination of shifting environmental exposures, including changes in diet, gut bacteria, vitamin D status, and viral exposure patterns, interacting with genetic susceptibility in ways that are still being untangled.